Many of the initial studies reported ERα expression in lung tumors using antibodies commonly used in breast cancer studies, thus false negative findings may have resulted if the antibodies targeted epitopes that are not present in splice variants found in lung tumors. Here, ESR1 is linked to breast cancer.